Surgentec

---

Surgentec brings a new advancement to the bone graft delivery arena with the Graftgun®

Our Graft Delivery System (GDS®) is designed to allow for universal, quick, and accurate bone graft delivery to a surgical site without the problems of a traditional funnel.Its patented, controlled delivery method is designed to safely dispense bone graft with enough pressure to easily fill any bone void during bone graft surgery. The Graftgun GDS includes SurGenTec’s loading device technology which provides surgeons the freedom to choose the bone graft that best suits their needs.

Our medical device technology can offer surgeons the best options for bone graft delivery during surgery. By using our patented GraftGun®, bone graft delivery can become less invasive and more accurate. Our Bone Graft Delivery systems were developed with surgeon and patient in mind. For more information, contact SurGenTec today. 

ADVANTAGES PROVIDED BY THE GRAFTGUN® ARE NUMEROUS AND INCLUDE:

• Single-use / disposable peel-pack – eliminates sterilization costs for each case
• Tactile feel for surgeon of orthobiologic filling void space – important because the surgeon needs to be able to judge when the void space has been adequately filled to insure the orthobiologic is contacting the adjacent vertebral body endplates. Insufficient quantity of bone graft can predispose to nonunion.
• Single-handed use – offers the surgeon ease of operation, stability and balance allowing use of other instruments simultaneously.
• Every squeeze of the GraftGun®’s trigger delivers approximately .25cc of orthobiologic. This allows the surgeon the confidence regarding the exact amount of orthobiologic inserted into the targeted area.
• Offers reproducible delivery of an orthobiologic in a controlled manner when using a delivery system.
• Offers ability to post-fill interbody cages, especially expandable cages that are difficult to fill prior to insertion.

OsteoFlo® NanoPutty® is the world’s first, and only quadphasic synthetic bone graft putty with nano-surface technology that allows for advanced bone healing. OsteoFlo® NanoPutty® has been designed to provide true nanobiology with an optimal resorption profile and superior handling characteristics. This novel synthetic bone graft putty is comprised of particles featuring four different biomaterials with nano-surface technology which are suspended in a unique combination of bioresorbable polymers. The quadphasic architecture helps allow for bone growth at different phases during the healing process to maximize bone growth potential, Nano-surface technology helps encourage osteocyte attachment.  The smaller particles used in the OsteoFlo® formulation are smaller than most synthetic bone grafts on the market. This helps maintain flowable properties for use in minimally invasive surgery. OsteoFlo® requires no mixing, reconstituting or preparation prior to use. The putty doesn’t harden and can flow through tiny apertures and voids. The exceptional handling characteristics make it first-in-class. The putty packs and molds where desired, without washing away during irrigation. OsteoFlo® comes in two packaging configurations including a standard syringe or pre-filled minimally invasive cartridge that may be used in conjunction with SurGenTec’s patented GraftGun®. Use with GraftGun® delivery system will save time in the operating room and help prevent cross contamination associated with loading bone graft in reusable funnels.

• Does not require any mixing, additives or other treatments prior to use.
• Doesn’t wash away under irrigation.
• Radiopaque under fluoroscopy.

ViMax is a viable fiber allograft that offers superior handling, packing and delivery where bone growth is necessary. The proprietary processing aims to preserve cell health, increase osteoinductivity, and reduce apoptosis due to the exposure of manufacturing stresses. ViMax contains all three physiologic elements (osteogenesis, osteoinduction, osteoconduction) necessary for bone formation. ViMax is available in vial or MIS cartridge options.

Contains the factors and cells needed for bone formation.

Contains endogeneous bone growth factors, including BMPs to recruit cells and signal bone formation.

Contains a three-dimensional scaffold ideally suited for bone formation.

Decorticate

Deliver

OSSIFY DBM Fiber Technology consists of 100% Demineralized Cortical Bone, creating a malleable porous structure when hydrated with any bioactive agent. The porous matrix provides an excellent osteoconductive scaffold with increased osteoinductive potential based on its larger surface area.

OSSIFY DBM Fiber Technology offers a combination of a porous surface structure and a bulk fibrous structure. This combination simultaneously provides a porous host for endogenous cells, and serves an attractive protein binding site for cell signaling to promote chemotaxis. OSSIFY DBM Fiber can serve as a superior vehicle for tissue integration when combined with the inherent biochemical properties of the scaffold.

Ossify DBM Putty is formable and flowable. OSSIFY resists irrigation and can be used to augment autologous cancellous or cortico-cancellous grafts.

Ossify DBM Putty is entirely derived from human allograft bone tissue. A unique processing method was invented to eliminate the need for extrinsic organic carriers that have no bioactivity or biological function.

Demineralized bone matrices are prepared by acid extraction of allograft bone, resulting in a loss of the majority of the mineralized components with retention of collagen and the non-collagenous proteins, including growth factors.

The efficacy of a demineralized bone matrix (DBM) as a bone-graft substitute or extender may be related to the total amount of bone morphogenetic protein (BMP) present, and the ratios of the different BMPs present. BMPs belong to the transforming growth factor (TGF) superfamily of proteins